A Message from The Oxford Club Dear Reader, Check out this amazing story. It involves an 82-year old named Paul with blood cancer. Paul went through six separate rounds of chemo... And all six failed. Then, a new company used AI to designate a new treatment for him. Two years later... Paul was cancer free. It's one of the most important and astonishing scientific breakthroughs of our time. And now... the small company behind the breakthrough is signing massive deals with big pharma. Up to $674 million with Merck... $1.2 billion with Bristol Myers Squibb... and up to an astonishing $5.2 billion to develop 15 potential treatments with Sanofi. We're talking about up to $7 billion worth of deals for a company that's worth a fraction of that amount. The stock trades for less than $10 today. But it might just become the #1 AI company in the world over the next few years. Go here to see the full story. Rachel Gearhart
Associate Publisher, The Oxford Club P.S. The same man who called 4 of the top 6 stocks in the markets from 2000 to 2020, is naming this his #1 stock going forward. He explains why here. | 
没有评论:
发表评论